MITOPOWER LLC
Therapeutics for patients with severe mitochondrial dysfunction
EAST PALO ALTO, United States · Founded 2021
- Headquarters
- EAST PALO ALTO, California
- Employees
- 1–10
- Founded
- 2021
- Business Model
- B2B
- Website
- mitopower.com
- Last Round
- GrantJan 2021
- Rounds
- 1
About
MitoPower is a biopharmaceutical company developing novel therapies for disorders associated with mitochondrial dysfunction, with a focus on liver and metabolic diseases. Their lead candidate MP-04 is a small molecule that enhances mitochondrial function, currently in pre-clinical development for alcoholic liver disease-associated hepatorenal syndrome (HRS). The company received a $6.5M NIH SBIR grant in collaboration with the University of Maryland Institute of Human Virology.
Summary
MITOPOWER LLC is a Biotech company based in EAST PALO ALTO, United States, founded in 2021. Its most recent funding was a Grant round in Jan 2021. Investors include National Cancer Institute.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jan 2021
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...